Cytokinetics Ownership | Who Owns Cytokinetics?
Cytokinetics Ownership Summary
Cytokinetics is owned by 115.50% institutional investors, 0.70% insiders. T. rowe price investment management is the largest institutional shareholder, holding 14.74% of CYTK shares. Vanguard Health Care Inv is the top mutual fund, with 3.41% of its assets in Cytokinetics shares.
CYTK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cytokinetics | 115.50% | 0.70% | -16.20% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 17.60M | 14.74% | $581.59M |
| Blackrock | 14.67M | 14.40% | $794.97M |
| Blackrock funding, inc. /de | 15.68M | 13.12% | $518.00M |
| Vanguard group | 11.92M | 10.13% | $560.52M |
| Fmr | 10.79M | 9.17% | $507.78M |
| Wellington management group llp | 7.89M | 6.70% | $371.08M |
| State street | 6.17M | 5.24% | $290.11M |
| Deep track capital, lp | 3.65M | 3.06% | $120.60M |
| Vestal point capital, lp | 2.98M | 2.49% | $98.29M |
| Geode capital management | 2.84M | 2.41% | $133.69M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 980.39K | 22.73% | $51.76M |
| Sarissa capital management lp | 588.36K | 12.59% | $19.44M |
| Melqart asset management (uk) | 1.33M | 6.26% | $43.83M |
| Boxer capital | 2.10M | 5.99% | $113.78M |
| Vestal point capital, lp | 2.98M | 5.18% | $98.29M |
| Deep track capital, lp | 3.65M | 3.87% | $120.60M |
| Dafna capital management | 398.10K | 3.63% | $13.15M |
| Great point partners | 150.00K | 3.22% | $4.96M |
| Cutter capital management, lp | 175.00K | 3.06% | $7.03M |
| Integral health asset management | 1.00M | 3.02% | $33.04M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 17.60M | 0.37% | 7.65M |
| Blackrock | 14.67M | 0.02% | 2.26M |
| Norges bank | 989.72K | 0.01% | 989.72K |
| Ubs group | 1.20M | 0.01% | 888.44K |
| Deep track capital, lp | 3.65M | 3.87% | 576.15K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Darwin global management | - | - | -4.58M |
| Marshall wace, llp | 21.23K | 0.00% | -2.01M |
| Pfm health sciences, lp | - | - | -1.76M |
| Point72 asset management | - | - | -1.72M |
| Westfield capital management co lp | - | - | -1.31M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 989.72K | 0.01% | 989.72K | $46.56M |
| Frazier life sciences management | 554.73K | 0.73% | 554.73K | $18.33M |
| Susquehanna portfolio strategies | 264.33K | 0.19% | 264.33K | $8.73M |
| Cutter capital management, lp | 175.00K | 3.06% | 175.00K | $7.03M |
| Jump financial | 151.29K | 0.06% | 151.29K | $5.00M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -1.00 |
| New england capital financial advisors | -1.00 |
| Financial gravity asset management | -2.00 |
| American capital advisory | -5.00 |
| Financial management professionals | -5.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 344 | -10.88% | 137,969,518 | 1.88% | 115 | 0.88% | 171 | -14.50% | 106 | -0.93% |
| Mar 31, 2025 | 25 | -93.40% | 16,158,180 | -87.73% | 13 | 0.11% | 15 | -91.28% | 5 | -96.09% |
| Dec 31, 2024 | 374 | -5.32% | 131,318,059 | -2.91% | 111 | 0.84% | 166 | -12.17% | 128 | 29.29% |
| Sep 30, 2024 | 390 | 0.52% | 135,010,879 | -0.29% | 114 | 0.65% | 187 | -6.50% | 99 | -2.94% |
| Jun 30, 2024 | 388 | -14.35% | 135,400,422 | 16.07% | 132 | 1.01% | 200 | -11.11% | 102 | -22.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 4.07M | 3.41% | - |
| iShares Core S&P Mid-Cap ETF | 3.89M | 3.25% | -6.99K |
| Vanguard US Total Market Shares ETF | 3.75M | 3.15% | 128.42K |
| Vanguard Total Stock Mkt Idx Inv | 3.72M | 3.11% | -77.64K |
| Vanguard Small Cap Index | 2.90M | 2.42% | -19.00K |
| iShares Russell 2000 ETF | 2.75M | 2.30% | -52.19K |
| T. Rowe Price Capital Appreciation | 2.44M | 2.04% | 41.02K |
| T. Rowe Price US Mid-Cap Growth Equity | 2.25M | 1.88% | 267.30K |
| T. Rowe Price Mid-Cap Growth | 2.25M | 1.88% | 268.00K |
| T. Rowe Price Small-Cap Value | 2.10M | 1.76% | 288.91K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 23, 2025 | Malik Fady Ibraham | EVP Research & Development | Sell | $98.56K |
| Sep 15, 2025 | Blum Robert I | President & CEO | Sell | $248.85K |
| Sep 09, 2025 | Malik Fady Ibraham | EVP Research & Development | Sell | $102.58K |
| Sep 02, 2025 | Kaye Edward M. MD | - | Sell | $337.80K |
| Sep 02, 2025 | Harrington Robert Arthur | - | Sell | $104.64K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 14 |
| 2025 Q2 | - | 19 |
| 2025 Q1 | - | 22 |
| 2024 Q4 | - | 20 |
| 2024 Q3 | - | 25 |
CYTK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools